ZA986715B - Pharmaceutical preparations of cilansetron stabilized against racemization - Google Patents

Pharmaceutical preparations of cilansetron stabilized against racemization

Info

Publication number
ZA986715B
ZA986715B ZA986715A ZA986715A ZA986715B ZA 986715 B ZA986715 B ZA 986715B ZA 986715 A ZA986715 A ZA 986715A ZA 986715 A ZA986715 A ZA 986715A ZA 986715 B ZA986715 B ZA 986715B
Authority
ZA
South Africa
Prior art keywords
cilansetron
pharmaceutical preparations
stabilized against
against racemization
racemization
Prior art date
Application number
ZA986715A
Other languages
English (en)
Inventor
Ingo Bonnacker
Hartmut Kohn
Gerhard Kristen
Christine Reichel
Original Assignee
Solvay Pharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Gmbh filed Critical Solvay Pharm Gmbh
Publication of ZA986715B publication Critical patent/ZA986715B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA986715A 1997-08-01 1998-07-28 Pharmaceutical preparations of cilansetron stabilized against racemization ZA986715B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19733271 1997-08-01

Publications (1)

Publication Number Publication Date
ZA986715B true ZA986715B (en) 1999-02-04

Family

ID=7837672

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA986715A ZA986715B (en) 1997-08-01 1998-07-28 Pharmaceutical preparations of cilansetron stabilized against racemization

Country Status (29)

Country Link
US (1) US5977127A (fr)
EP (1) EP0895782B1 (fr)
JP (1) JP4324260B2 (fr)
KR (1) KR100515201B1 (fr)
CN (1) CN1117565C (fr)
AR (1) AR010178A1 (fr)
AT (1) ATE283706T1 (fr)
AU (1) AU743043B2 (fr)
BR (1) BR9803730A (fr)
CA (1) CA2244389C (fr)
CZ (1) CZ295072B6 (fr)
DE (2) DE19813661A1 (fr)
DK (1) DK0895782T3 (fr)
DZ (1) DZ2560A1 (fr)
ES (1) ES2234051T3 (fr)
HK (1) HK1017611A1 (fr)
HU (1) HUP9801712A3 (fr)
ID (1) ID20685A (fr)
IL (1) IL125403A (fr)
NO (1) NO323229B1 (fr)
NZ (1) NZ331083A (fr)
PL (1) PL191767B1 (fr)
PT (1) PT895782E (fr)
RU (1) RU2199318C2 (fr)
SK (1) SK284916B6 (fr)
TR (1) TR199801432A2 (fr)
TW (1) TW509570B (fr)
UA (1) UA62924C2 (fr)
ZA (1) ZA986715B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7452545B2 (en) * 2001-11-13 2008-11-18 Yu Ruey J Oligosaccharide aldonic acids and their topical use
PT1372611E (pt) * 2001-03-26 2006-08-31 Novartis Ag Composicao farmaceutica compreendendo uma estaurosporina francamente soluvel em agua, um tensioactivo et um polimero soluvel em agua
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
AU2004204825B2 (en) * 2003-01-13 2007-07-19 Dynogen Pharmaceuticals, Inc. Method of treating functional bowel disorders
US20040147510A1 (en) * 2003-01-13 2004-07-29 Dynogen Pharmaceuticals, Inc. Method of treating nausea, vomiting, retching or any combination thereof
DE602004007225T2 (de) * 2003-04-04 2008-03-06 Dynogen Pharmaceuticals Inc., Waltham Methode zur behandlung von erkrankungen der unteren harnwege
US7820690B2 (en) * 2004-03-19 2010-10-26 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting a non-digestive tract derived abdominal disorder associated with pain using a 5-HT, receptor antagonist
US20060293309A1 (en) * 2005-03-28 2006-12-28 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
CA2733778A1 (fr) 2008-08-14 2010-02-18 Hiroshi Uchida Composition pharmaceutique stabilisee
JPWO2021100728A1 (fr) 2019-11-20 2021-05-27

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3885357T2 (de) * 1987-06-29 1994-03-24 Duphar Int Res Anellierte Indolderivate.
DE4238553A1 (de) * 1992-11-14 1994-05-19 Kali Chemie Pharma Gmbh Neue Imidazol-1-yl-Verbindungen enthaltende Arzneimittel
AU702594B2 (en) * 1995-10-13 1999-02-25 Duphar International Research B.V. Process for the preparation of enantiomerically pure imidazolyl compounds

Also Published As

Publication number Publication date
ID20685A (id) 1999-02-18
SK284916B6 (sk) 2006-02-02
JP4324260B2 (ja) 2009-09-02
IL125403A (en) 2001-11-25
CN1207292A (zh) 1999-02-10
ATE283706T1 (de) 2004-12-15
AU7863098A (en) 1999-02-11
KR19990023194A (ko) 1999-03-25
UA62924C2 (en) 2004-01-15
CA2244389A1 (fr) 1999-02-01
RU2199318C2 (ru) 2003-02-27
KR100515201B1 (ko) 2005-12-09
TW509570B (en) 2002-11-11
IL125403A0 (en) 1999-03-12
CZ295072B6 (cs) 2005-05-18
NZ331083A (en) 2000-01-28
PT895782E (pt) 2005-02-28
PL327786A1 (en) 1999-02-15
CZ236798A3 (cs) 1999-02-17
EP0895782B1 (fr) 2004-12-01
PL191767B1 (pl) 2006-06-30
TR199801432A3 (tr) 1999-02-22
US5977127A (en) 1999-11-02
CN1117565C (zh) 2003-08-13
ES2234051T3 (es) 2005-06-16
NO983540L (no) 1999-02-02
HUP9801712A3 (en) 2001-08-28
DE19813661A1 (de) 1999-02-04
HK1017611A1 (en) 1999-11-26
JPH1192369A (ja) 1999-04-06
EP0895782A3 (fr) 2001-01-31
HU9801712D0 (en) 1998-09-28
AR010178A1 (es) 2000-05-17
TR199801432A2 (xx) 1999-02-22
AU743043B2 (en) 2002-01-17
DE59812317D1 (de) 2005-01-05
CA2244389C (fr) 2008-01-15
NO323229B1 (no) 2007-02-05
DZ2560A1 (fr) 2003-02-15
NO983540D0 (no) 1998-07-31
DK0895782T3 (da) 2005-01-03
SK100998A3 (en) 1999-02-11
HUP9801712A2 (hu) 1999-04-28
EP0895782A2 (fr) 1999-02-10
BR9803730A (pt) 2000-03-28

Similar Documents

Publication Publication Date Title
EG26803A (en) Fixed pharmaceuticals of gabainetin or pregabalin with amino acid
IL139235A0 (en) Pharmaceutical preparations
GB9718690D0 (en) Pharmaceutical preparations for intranasal administration
PL330903A1 (en) Aqueous preparations of peptides
PL341309A1 (en) Method of preventing overdosage of opioidic preparations
PL336889A1 (en) Preparations of activated protein c
PL330814A1 (en) Compounds for and methods of delivering pharmaceutical preparations and their application
PL335974A1 (en) Method of orally administering proteins
DK0981375T3 (da) Farmaceutiske præparater indeholdende plasmaprotein
IL131259A0 (en) Topical drug preparations
PL334976A1 (en) Pharmaceutic preparations containing amoxycyclin and clavulate
ZA982872B (en) Pharmaceutical formulation
ZA986715B (en) Pharmaceutical preparations of cilansetron stabilized against racemization
PL339085A1 (en) Recombinative expression of insulin peptide c
ZA983065B (en) Inhibitors of protein farnesyltranferase
HU9502426D0 (en) Compounds of pharmaceutical activity
DK0925273T3 (da) Farmaceutiske præparater indeholdende 4-oxo-butansyrer
PL328763A1 (en) Misolastin containing pharmaceutical preparations of prolonged action
GB9709739D0 (en) Pharmaceutical formulation
PL334769A1 (en) Derivatives of 5-aroylnaphtene
HUP9602220A2 (en) Substituted 4h-piranes and pharmaceutical preparations containing them
PL308307A1 (en) 3-substituted 2-oxyindolo-1-carboxylamide pharmaceutical preparations
ZA961081B (en) Pharmaceutical preparations for tnf inhibition
EP1004309A4 (fr) Preparations aqueuses contenant de l'israpafant
IL119208A0 (en) Pharmaceutical preparations containing ketoprofen